Skip to content
OpenCapital
Get started

Virtus Investment Partners VRTS Indefinite-Lived Research and Development Assets

Indefinite-Lived Research and Development Assets at other companies

Blackrock logo
BlackrockBLK
——
Cohen & Steers logo
Cohen & SteersCNS
——

Other financials

Income statement

See full
Revenue$199.5M-8.4%
Operating income$15.4M-57.8%
Net income$6.2M-78.1%
EPS (diluted)$1.05-74.1%

Balance sheet

See full
Cash & equivalents$274.4M+25.0%
Total debt$533.4M+75.6%
Total equity$917.4M+2.7%
Total assets$4.6B+23.7%

Cash flow

See full
Operating cash flow$35.9M+1,048%
CapEx$2.4M-20.9%
Free cash flow$33.5M+595%

Valuation

See full
Market cap$926.21M-25.0%
Enterprise value$1.19B-9.9%
P/E8.1×-0.5×
P/S1.1×-0.3×

Profitability

See full
Operating margin17.7%-3.0pp
Net margin13.7%-2.1pp
FCF margin-4%-6.9pp

Returns & leverage

See full
Return on equity12.6%-3.6pp
Debt / equity0.6×+0.2×

Where this comes from

Reported directly by Virtus Investment Partners in its filing.

Tagged under the XBRL concept us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill.

The official record: Virtus Investment Partners’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Virtus Investment Partners's indefinite-lived research and development assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Virtus Investment Partners's indefinite-lived research and development assets?
Virtus Investment Partners (VRTS) reported indefinite-lived research and development assets of $42.3M in Q1 2026.
How has Virtus Investment Partners's indefinite-lived research and development assets changed year-over-year?
Virtus Investment Partners's indefinite-lived research and development assets decreased by 0.0% year-over-year, from $42.3M to $42.3M.
What is the long-term trend for Virtus Investment Partners's indefinite-lived research and development assets?
Over 5 years (2020 to 2025), Virtus Investment Partners's indefinite-lived research and development assets has grown at a -0.6% compound annual growth rate (CAGR), from $43.52M to $42.3M.